Newsletter | December 17, 2019

12.17.19 -- Novel Chemistry Reaction Offers Shortcut For Many New Drug Molecules

  Maximize Your Market Potential With Innovative Softgel Technologies

Softgels are becoming an increasingly popular dosage form to help you overcome low solubility challenges, increase new revenue streams, maximize your market potential, and more. Working with the right vendor is key. Learn more about the value we bring to pharmaceutical and consumer healthcare companies, the patient benefits associated with softgels, and the diverse technologies Thermo Fisher Scientific has to offer. Click here.

Industry Insights
Novel Uses For Oral Solid Doses Driving Lifecycle Management Strategies
Article | By Anil Kane, Ph.D., Thermo Fisher Scientific

With few potential blockbuster drugs in the pharma pipeline right now, drug companies are increasingly looking at other options to meet the needs of patients and increase revenue in the oral solid dosage arena.

Why, Why, Why… ELISA? A Look At The Benchmark HCP Assay
Article | By Joe Hirano, GE Healthcare Life Sciences

Biologics developers and manufacturers demand an accurate and reliable assay for host cell protein (HCP) quantitation. Let’s take a close look at why analytical scientists turn to the ELISA, and how it fits into process development.

Novel Cell-Based Screening Assay For Cholesterol Biosynthetic Pathway Inhibition
White Paper | GVK Biosciences

A client was exploring the possibility of re-purposing an internal collection of antifungal CYP51A1 inhibitors for targeting cancers. Learn how a CYP51A1 inhibitor screening assay and screening of client compounds moved the project forward in a cost-effective manner. 

Most Popular News
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.